Effect of Prolonged-Release Pirfenidone on Renal Function in Septic Acute Kidney Injury Patients: A Double-Blind Placebo-Controlled Clinical Trial
Background. There is no treatment for septic acute kidney injury (sAKI). The anti-inflammatory activity of prolonged-release pirfenidone (PR-PFD) could be beneficial in this clinical setting. Methods. This study was a double-blind randomized clinical trial in sAKI patients with nephrology consultati...
Saved in:
Main Authors: | Jonathan S. Chávez-Iñiguez, Jorge L. Poo, Miguel Ibarra-Estrada, Leonel García-Benavides, Guillermo Navarro-Blackaller, Cynthia Cervantes-Sánchez, Eduardo Nungaray-Pacheco, Ramón Medina-González, Juan Armendariz-Borunda, Guillermo García-García |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | International Journal of Nephrology |
Online Access: | http://dx.doi.org/10.1155/2021/8833278 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pirfenidone Accelerates Wound Healing in Chronic Diabetic Foot Ulcers: A Randomized, Double-Blind Controlled Trial
by: Luz E. Gasca-Lozano, et al.
Published: (2017-01-01) -
Acute Kidney Injury Caused by Obstructive Nephropathy
by: Jonathan S Chávez-Iñiguez, et al.
Published: (2020-01-01) -
Pirfenidone Alleviates Choroidal Neovascular Fibrosis through TGF-β/Smad Signaling Pathway
by: Chuang Gao, et al.
Published: (2021-01-01) -
El Estado de derecho y la condicionalidad del fondo de recuperación: ¿bloqueo institucional o falta de voluntad política?
by: Guillermo Íñiguez
Published: (2020-01-01) -
Epigenome-wide DNA methylation profiling in septic and non-septic patients with similar infections: potential use as sepsis biomarkers
by: Ian López-Cruz, et al.
Published: (2025-01-01)